Track the Iovance Biotherapeutics, INC. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, Iovance Biotherapeutics, INC. has logged 75 reports. Market capitalisation: €1.7bn. The latest transaction was disclosed on 3 June 2026 (Levée d'options). Among the most active insiders: BILINSKY IGOR. The full history is openly available.
75
Insider Decl.
0
Thresholds
€135m
17 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Iovance Biotherapeutics, INC. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
34Σ signal
Buys €135m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,008 of 26,120 companies
14.7
score / 100
Value
22
Quality
7
FCF yld-4.4%
Earn yld-5.6%
EV/EBITDA·
ROE-28%
Gross mgn·
Net mgn-49%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.